Genetic analysis of patients with hypertrophic cardiomyopathy

Standard

Genetic analysis of patients with hypertrophic cardiomyopathy. / Dementyeva, E. V.; Vyatkin, Yu V.; Kretov, E. I. и др.

в: Genes and Cells, Том 15, № 3, 2020, стр. 68-73.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Dementyeva, EV, Vyatkin, YV, Kretov, EI, Elisaphenko, EA, Medvedev, SP & Zakian, SM 2020, 'Genetic analysis of patients with hypertrophic cardiomyopathy', Genes and Cells, Том. 15, № 3, стр. 68-73. https://doi.org/10.23868/202011011

APA

Dementyeva, E. V., Vyatkin, Y. V., Kretov, E. I., Elisaphenko, E. A., Medvedev, S. P., & Zakian, S. M. (2020). Genetic analysis of patients with hypertrophic cardiomyopathy. Genes and Cells, 15(3), 68-73. https://doi.org/10.23868/202011011

Vancouver

Dementyeva EV, Vyatkin YV, Kretov EI, Elisaphenko EA, Medvedev SP, Zakian SM. Genetic analysis of patients with hypertrophic cardiomyopathy. Genes and Cells. 2020;15(3):68-73. doi: 10.23868/202011011

Author

Dementyeva, E. V. ; Vyatkin, Yu V. ; Kretov, E. I. и др. / Genetic analysis of patients with hypertrophic cardiomyopathy. в: Genes and Cells. 2020 ; Том 15, № 3. стр. 68-73.

BibTeX

@article{73bfc03e92f84f55844741439097575a,

title = "Genetic analysis of patients with hypertrophic cardiomyopathy",

abstract = "Hypertrophic cardiomyopathy is one of the most common cardiovascular pathologies. In most cases, the disease is caused by mutations in genes encoding for sarcomeric proteins. However, high genetic heterogeneity of hypertrophic cardiomyopathy makes it difficult to interpret results of patients{\textquoteright} genetic studies. The aim of this study is to check if hypertrophic cardiomyopathy in 15 patients suffering from the disease is due to genetic causes. In the course of genetic analysis, a known pathogenic mutation p.Gln1233Ter in MYBPC3 causing hypertrophic cardiomyopathy was found only in one patient. In six patients, mutations with uncertain clinical significance were identified in hypertrophic cardiomyopathy-associated genes LDB3, MYBPC3, MYH7, MYL2, and MYPN. Three of the mutations, p.Ile730Asn in LDB3, p.Asn515del in MYBPC3, p.Arg955Trp in MYPN were found for the first time in association with hypertrophic cardiomyopathy. In two patients, novel mutations, p.Ser478Trp in MYBPC3 and p.Asn989Ile in MYPN, were identified. Thus, hypertrophic cardiomyopathy may be accounted for by genetic causes in 8 patients more but the role of these mutations in the disease development needs to be clarified.",

keywords = "Hypertrophic cardiomyopathy, Mutation, Sarcomeric proteins",

author = "Dementyeva, {E. V.} and Vyatkin, {Yu V.} and Kretov, {E. I.} and Elisaphenko, {E. A.} and Medvedev, {S. P.} and Zakian, {S. M.}",

year = "2020",

doi = "10.23868/202011011",

language = "English",

volume = "15",

pages = "68--73",

journal = "Genes and Cells",

issn = "2313-1829",

publisher = "Human Stem Cells Institute OJSC (HSCI)",

number = "3",

}

RIS

TY - JOUR

T1 - Genetic analysis of patients with hypertrophic cardiomyopathy

AU - Dementyeva, E. V.

AU - Vyatkin, Yu V.

AU - Kretov, E. I.

AU - Elisaphenko, E. A.

AU - Medvedev, S. P.

AU - Zakian, S. M.

PY - 2020

Y1 - 2020

N2 - Hypertrophic cardiomyopathy is one of the most common cardiovascular pathologies. In most cases, the disease is caused by mutations in genes encoding for sarcomeric proteins. However, high genetic heterogeneity of hypertrophic cardiomyopathy makes it difficult to interpret results of patients’ genetic studies. The aim of this study is to check if hypertrophic cardiomyopathy in 15 patients suffering from the disease is due to genetic causes. In the course of genetic analysis, a known pathogenic mutation p.Gln1233Ter in MYBPC3 causing hypertrophic cardiomyopathy was found only in one patient. In six patients, mutations with uncertain clinical significance were identified in hypertrophic cardiomyopathy-associated genes LDB3, MYBPC3, MYH7, MYL2, and MYPN. Three of the mutations, p.Ile730Asn in LDB3, p.Asn515del in MYBPC3, p.Arg955Trp in MYPN were found for the first time in association with hypertrophic cardiomyopathy. In two patients, novel mutations, p.Ser478Trp in MYBPC3 and p.Asn989Ile in MYPN, were identified. Thus, hypertrophic cardiomyopathy may be accounted for by genetic causes in 8 patients more but the role of these mutations in the disease development needs to be clarified.

AB - Hypertrophic cardiomyopathy is one of the most common cardiovascular pathologies. In most cases, the disease is caused by mutations in genes encoding for sarcomeric proteins. However, high genetic heterogeneity of hypertrophic cardiomyopathy makes it difficult to interpret results of patients’ genetic studies. The aim of this study is to check if hypertrophic cardiomyopathy in 15 patients suffering from the disease is due to genetic causes. In the course of genetic analysis, a known pathogenic mutation p.Gln1233Ter in MYBPC3 causing hypertrophic cardiomyopathy was found only in one patient. In six patients, mutations with uncertain clinical significance were identified in hypertrophic cardiomyopathy-associated genes LDB3, MYBPC3, MYH7, MYL2, and MYPN. Three of the mutations, p.Ile730Asn in LDB3, p.Asn515del in MYBPC3, p.Arg955Trp in MYPN were found for the first time in association with hypertrophic cardiomyopathy. In two patients, novel mutations, p.Ser478Trp in MYBPC3 and p.Asn989Ile in MYPN, were identified. Thus, hypertrophic cardiomyopathy may be accounted for by genetic causes in 8 patients more but the role of these mutations in the disease development needs to be clarified.

KW - Hypertrophic cardiomyopathy

KW - Mutation

KW - Sarcomeric proteins

UR - http://www.scopus.com/inward/record.url?scp=85101250547&partnerID=8YFLogxK

U2 - 10.23868/202011011

DO - 10.23868/202011011

M3 - Article

AN - SCOPUS:85101250547

VL - 15

SP - 68

EP - 73

JO - Genes and Cells

JF - Genes and Cells

SN - 2313-1829

IS - 3

ER -

ID: 27964131